HSPA8 and cancer: In addition, abnormal phosphorylation of HSC70 (HSP70) has been found to inhibit transportation of methotrexate anti-cancer agents into tumor cells, suggesting de-phosphorylation of HSC70 as a viable strategy to enhance the sensitivity to methotrexate [183].